Integrated multi-omics analysis reveals NOL11 as a novel prognostic biomarker for hepatocellular carcinoma
Our findings suggest that NOL11 is a promising diagnostic and prognostic biomarker for HCC, providing new insights into the treatment decisions for HCC patients.
Authors
- Jiaheng Yang (ORCID: https://orcid.org/0000-0002-0039-3794)
- Maosen Guo
- Lixia Xu (ORCID: https://orcid.org/0000-0002-1818-6267)
- Zi Ye (ORCID: https://orcid.org/0000-0001-5393-5959)
- Zhe Li (ORCID: https://orcid.org/0000-0002-0394-9700)
- Yijie Zhu
- Feng Dong (ORCID: https://orcid.org/0000-0002-4241-9497)
- Bin Han (ORCID: https://orcid.org/0000-0002-7581-6202)
- Yilong Fu
- Yanfei Wei
Institutions
- Henan University of Science and Technology (CN)
- Henan Academy of Sciences (CN)
- Second Affiliated Hospital of Zhengzhou University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1186/s12885-025-15113-9
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00